1-4 of 4
C Boyer
Close
Sort by
Journal Articles

PATH-HHT, a Double-Blind, Randomized, Placebo-Controlled Trial in Hereditary Hemorrhagic Telangiectasia Demonstrates That Pomalidomide Reduces Epistaxis and Improves Quality of Life

Hanny Al-Samkari, Raj S. Kasthuri, Vivek Iyer, Allyson M Pishko, Jake E Decker, Kevin J Whitehead, Miles B Conrad, Clifford Weiss, Joseph Parambil, Marc Stuart Zumberg, Jenny Y Zhou, Holly C Boyer, Vernon R Sutton, Marshall Mazepa, Lauren Bradley, Marianne S. Clancy, Lisa Wisniewski, Benjamin Carper, Diane Catellier, Sonia M Thomas, Keith R. McCrae
Journal: Blood
Blood (2023) 142 (Supplement 2): LBA-3.
https://doi.org/10.1182/blood-2023-191983
Published: 2023
Journal Articles

Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia

J Amiral, A Marfaing-Koka, M Wolf, MC Alessi, B Tardy, C Boyer-Neumann, AM Vissac, E Fressinaud, M Poncz, D Meyer
Journal: Blood
Blood (1996) 88 (2): 410–416.
https://doi.org/10.1182/blood.V88.2.410.bloodjournal882410
Published: 1996
Journal Articles

Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III

M Wolf, C Boyer, A Tripodi, D Meyer, MJ Larrieu, PM Mannucci
Journal: Blood
Blood (1985) 65 (2): 496–500.
https://doi.org/10.1182/blood.V65.2.496.496
Published: 1985
Journal Articles

Causal mechanisms of multiple acquired red cell enzyme defects in a patient with acquired dyserythropoiesis

A Kahn, D Cottreau, C Boyer, J Marie, C Galand, P Boivin
Journal: Blood
Blood (1976) 48 (5): 653–662.
https://doi.org/10.1182/blood.V48.5.653.653
Published: 1976